Navigation Links
The Society for Minimally Invasive Spine Surgery Announces Agreement With joimax® to Support Creation and Launch of SMISS Registry for Endoscopic Spine Surgery
Date:10/20/2011

SAN DIEGO, October 20, 2011 /PRNewswire/ --

The Society for Minimally Invasive Spine Surgery (SMISS), San Diego, CA and joimax®, Karlsruhe, Germany announced today the signing of an agreement to support the SMISS Registry as a founding sponsor for creation and launch of the SMISS Spine Registry for Minimally Invasive Endoscopic Spine Surgery. The SMISS Spine Registry was designed to collect valuable data concerning decreased hospitalization, recovery times, and complication rates of endoscopic spine procedures, as well as increased quality of life measures, subject satisfaction, and cost effectiveness. In today's rapidly changing healthcare climate, it is imperative to ensure the ongoing availability of this data regarding efficiencies of care and quality of outcomes.

SMISS has assembled an outstanding research team with extensive experience within the spine field. The Principal Investigator for the Registry, Choll Kim, M. D., Ph.D, Executive Director and Board of Directors Member of SMISS states: "We are excited to partner with joimax® in the launch of the SMISS Registry, a project that will produce the relevant data collection and management necessary for the continued growth of minimally invasive endoscopic spine surgery. The Society will lead the way in the collection of minimally invasive spine surgery outcomes and cost data. SMISS is positioned to become the model for successful spine research."

"joimax® and SMISS are ideal partners to begin this important project in spinal endoscopy. The data collected will assist both parties in furthering the development of minimally invasive endoscopic spinal surgery, which is a great benefit to patients around the world," said Wolfgang Ries, CEO and Founder of joimax. "We are pleased to provide funding for this important project."

This three year, multi-centered project will commence patient enrollment in late 2011. The Registry is expected to enroll a minimum of 250 patients during the first phase of the project.

About joimax®

The young and innovative medical technology company dedicates itself to combined surgical technologies ("joined minimal access technologies"), particularly in the area of spinal treatment. joimax® develops, produces and markets tried and tested user-friendly systems for endoscopic spinal surgery, always staying on top with the latest technology. With extensively trained staff amassing years of industry experience, joimax® has acquired key skills in the areas of equipment technology, systems, hard and software, instrumentation, endoscopes, disposable products, implants and x-ray protection. With the comprehensive education program which incorporates workshops, visitations and operations accompanied by an experienced application specialist, the implementation of the procedure will be supported right from the start. joimax® considers itself a partner of operating physicians, bearing the motto "helping to treat patients!" More information is available at http://www.joimaxusa.com. Contact: Courtney Sheedy.

About SMISS
The Society for Minimally Invasive Spine Surgery is located in San Diego, CA. The SMISS Mission is to improve patient care by advancing the practice of effective minimally invasive spine surgery through education, research, and advocacy. For more information, visit http://www.smiss.org. Contact: Amy Johnson.


Contact:
joimax GmbH
Dagmar Kyewski
Amalienbadstr. 41
RaumFabrik 61
D-76227 Karlsruhe
Germany
Ph: +49(0)721-25514-0
info@joimax.com
http://www.joimax.com



'/>"/>
SOURCE joimax GmbH
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
3. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
4. Boston Scientific Announces Schedule for European Society of Cardiology Congress 2007
5. TrialCheck(R) Cancer Clinical Trial Matching Interface to Debut on American Cancer Society Web Site
6. Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress
7. The Leukemia & Lymphoma Society is Encouraged by Promising News for Myeloma Patients
8. ECLIPSE Data on Effects of Otsukas Investigational Novel Treatment, Tolvaptan, on Advanced Heart Failure Patients Hemodynamics and Urine Output Featured in Heart Failure Society of Americas Late Breaking Trials
9. The Leukemia & Lymphoma Society and Cleveland Clinic Taussig Cancer Institute Announce Groundbreaking Partnership to Accelerate Drug Approvals
10. Preimplantation Genetic Diagnosis International Society Refutes American Society of Reproductive Medicine Opinion - States Preimplantation Genetic Screening is Beneficial When Performed in Experienced Centers
11. New MIRCERA(R) Data Analyses to be Featured at the American Society of Nephrology Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... TEL AVIV, Israel , March 28, 2017 ... . This new business entity, Emosis Ltd, headquartered in ... and development of novel assays complementing the mother company existing technology ... support commercialization and sales development of Emosis kits. ... This strategic move starts building Emosis ...
(Date:3/28/2017)... , March 28, 2017  AcelRx Pharmaceuticals, ... on the development and commercialization of innovative therapies ... that the European Medicines Agency (EMA) has notified ... 30 mcg) Marketing Authorisation Application (MAA) has passed ... MAA is underway. The MAA for ARX-04 (known ...
(Date:3/28/2017)... RXi Pharmaceuticals Corporation (NASDAQ: RXII), a ... significant unmet medical needs, today announced that it ... Office (JPO) for the composition of matter of ... the treatment or prevention of fibrotic disorders, including ... retinopathy (Japanese Patent #: 6060071).  This patent includes ...
Breaking Medicine Technology:
(Date:3/28/2017)... ... March 28, 2017 , ... ... the University of Pittsburgh Medical Center (UPMC) will acquire QuikClot® Bleeding Control Kits® ... The program, developed in association with efforts by the American College of Surgeons, ...
(Date:3/28/2017)... ... March 28, 2017 , ... Award-winning medical group Allied ... as new board chair for Orange County health care system CalOptima Friday. CalOptima ... soon-to-be former chair Mark Refowitz’s term, which runs through June 30 of this ...
(Date:3/28/2017)... ... March 28, 2017 , ... In its ongoing effort ... has recently developed and published an informational resource that addresses frequently asked questions. ... common inquiries the site’s team of third party administrator (TPA) contributors regularly receives ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... Advanced Surgical, Inc. is thrilled to offer the recently FDA-approved Obalon Balloon System ... procedure adds to SkyLex Advanced Surgical’s already comprehensive list of weight-loss services. ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... Oily skin is a common and unwelcomed ... Advanced Dermatology has a lot to offer to the discussion of dealing with excess ... is that there are many home remedies that can help remove the oily shine while ...
Breaking Medicine News(10 mins):